Metabolic Research Institute (MRI) is a leading clinical research company founded in 1996 and headquartered in the United States. MRI specializes in conducting clinical trials to find treatments that improve health, with a focus on biotechnology and health care industries. The company's commitment to providing the fastest and safest ways to conduct clinical research is encapsulated in its slogan, "Metabolic Research Institute’s clinical trials are the fastest and safest ways to find treatments that improve health." MRI is located at 1515 North Flagler Drive, Suite 440, West Palm Beach Florida 33401, where all study-related appointments for qualified clinical participants take place. As of now, there is no publicly available information regarding MRI's last investment or the investors involved in the latest round of funding. However, given the company's extensive experience and expertise in conducting valuable clinical trials, MRI presents an intriguing opportunity for potential investors interested in the biotechnology and healthcare sectors. With its strong track record and dedication to advancing medical treatments, MRI's future fundraising activities could be of interest to venture capital firms looking to support innovative companies at the forefront of medical research and development.
There is no investment information
No recent news or press coverage available for Metabolic Research Institute.